Skip to content

A comparison of the effects of Triamcinolone and Dexmedetomidine and Magnesium sulfate in caudal neuroplasty in chronic low back pain

A comparison of the effects of Triamcinolone and Dexmedetomidine and Magnesium sulfate in caudal neuroplasty in chronic low back pain

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20111102007984N32
Enrollment
60
Registered
2022-09-02
Start date
2020-03-03
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain. Low back pain

Interventions

Intervention 1: Control group: which undergoes epidural epidural injection using 2-3 ml of Xylocaine (without preservative and without epinephrine) by a 17-gauge spinal injection needle. Intervention

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Chronic low back pain more than six months +/- radiculopathyModerate to severe pain score (> 3, based on the Visual Analog Scale)Being at the age of 40-70 years Inadequate response to conservative and physiotherapy treatments after three monthsAmerican Anesthesiologists Classification (ASA) I-IIDisc protrusion in MRI

Exclusion criteria

Exclusion criteria: Severe canal stenosis (more than two thirds in axial MRI view) Sequestrated disc (fragmented) Decreased disc height more than 60% Sever spinal deformity Spinal tumors Vertebral fracture Spondylolisthesis Grade>2 Local or systemic infection Taking anticoagulants Drug abuse History of drug reaction Sever psychological disorders Pregnancy and lactation Severe or sudden neurological deficit such as urinary or fecal incontinence Body Mass Index (BMI) > 35 Patient's refusal Diabetes mellitus MRI contraindications (cardiac pacemaker, defibrillator, aortic aneurysm clips) Impossible prone positioning

Design outcomes

Primary

MeasureTime frame
Visual analog scale. Timepoint: At the beginning of the study (before the intervention) and 14, 30, 90 and 180 days after the intervention. Method of measurement: Visual Analogue Scale.;Oswestry Disability Index. Timepoint: At the beginning of the study (before the intervention) and 14, 30, 90 and 180 days after the intervention. Method of measurement: Oswestry Low Back Pain Disability Questionnaire.

Secondary

MeasureTime frame
The amount of painkiller used. Timepoint: At the beginning of the study (before the intervention) and 14, 30, 90 and 180 days after the intervention. Method of measurement: Preset form for recording the amount of painkiller used.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnad Imani

Iran University of Medical Sciences

Farnadimani@yahoo.com+98 21 6651 5758

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026